Squamous cell carcinoma

Introduction

Squamous cell carcinoma is a type of skin cancer that arises from squamous cells, the flat cells found in the outer layer of the skin (the epidermis) and also in mucous membranes. It’s one of the most common skin cancers worldwide, second only to basal cell carcinoma, and can affect other areas lined by squamous cells—think mouth, throat or cervix. Left untreated, it can invade deeper tissues or even spread (metastasize), impacting health and daily life. In this article we’ll explore key symptoms, causes, diagnostic steps, treatments and what to expect in the long run even tips to reduce your risk.

Definition and Classification

Medically, Squamous cell carcinoma (SCC) refers to a malignant tumor originating from squamous epithelial cells. These cells cover surfaces such as the skin’s exterior and the linings of organs like the lungs, esophagus, and cervix. SCCs are classified by:

• Site of origin: Cutaneous (skin), mucosal (oral, genital), or visceral (lung, bladder).
• Behavior: Often categorized as low-risk (well-differentiated, slow-growing) or high-risk (poorly differentiated, invasive).
• Stage: Based on size, depth of invasion, and presence of metastases (using TNM staging).

Subtypes include verrucous carcinoma (slow-growing, wart-like) and spindle cell carcinoma (desmoplastic, rarer). Clinically relevant distinctions matter: cutaneous SCC is generally less aggressive than mucosal or visceral forms but demands prompt attention.

Causes and Risk Factors

The exact cause of squamous cell carcinoma isn’t always pinpointed, but several contributing elements are well-known. Chronic exposure to ultraviolet (UV) radiation sunlight or tanning beds is the leading environmental factor for cutaneous SCC. Imagine decades of weekend beach trips without sunscreen: DNA damage accumulates in skin cells, increasing mutation rates over time. Other risk factors include:

• Age and fair skin: Lighter-skinned individuals and people over 60 have higher incidence due to less melanin protection and lifelong UV exposure.
• Immunosuppression: Organ transplant recipients or patients on chronic immunosuppressive drugs have up to 65-fold increased risk.
• Chronic wounds or scars: Anything from burn scars to non-healing leg ulcers can transform into SCC over years—a process sometimes called Marjolin’s ulcer.
• Human papillomavirus (HPV): Certain strains (e.g., HPV-16) are linked to mucosal SCC in the oropharynx or genital region.
• Genetic syndromes: Xeroderma pigmentosum, a rare DNA-repair defect, predisposes to early-onset SCC.
• Chemical exposures: Arsenic, chlorinated hydrocarbons, and polycyclic aromatic hydrocarbons are implicated in occupational settings.
• Smoking and alcohol: Especially for mucosal SCC of the mouth, throat and larynx—synergistic effects raise risk drastically.

Modifiable risks include sun protection habits, tobacco and alcohol avoidance, and treating chronic wounds. Non-modifiable risks are genetic predisposition and age. Some causes like immunosuppression aren’t fully preventable, underscoring the need for vigilant skin exams and health surveillance.

Pathophysiology (Mechanisms of Disease)

Squamous cell carcinoma develops through a multistep process of mutation accumulation. Under normal circumstances, squamous cells divide in a controlled way to replace old cells. UV radiation, chemicals or HPV infection can damage DNA in these cells. Key disruptions include:

• Oncogene activation: Genes like RAS may become stuck in an “on” position, driving excessive cell proliferation.
• Tumor suppressor gene loss: p53, a guardian of genomic integrity, is mutated in up to 50–60% of cutaneous SCCs, impairing apoptosis of damaged cells.
• Telomerase reactivation: Cancer cells often reactivate telomerase, preventing telomere shortening and enabling limitless replication.
• Chronic inflammation: Cytokines and growth factors in a persistently inflamed area (e.g., a burn scar) promote cell survival and angiogenesis.
• Immune evasion: Altered expression of surface markers helps SCC cells hide from cytotoxic T-lymphocytes.

As these molecular events compound, cells lose normal attachments to neighbors (via E-cadherin downregulation), gain invasiveness through matrix metalloproteinases, and infiltrate the dermis or deeper tissues. Once past the basement membrane, SCC can access lymphatics and blood vessels, especially in high-risk subtypes, leading to metastatic spread.

Symptoms and Clinical Presentation

Symptoms of Squamous cell carcinoma vary by location but share common themes of abnormal growth, ulceration, and sometimes pain. On the skin you might see:

• A persistent, scaly red patch that may crust or bleed easily, often on sun-exposed areas like the face, ears, or hands.
• A raised bump with a central ulcer or depression, sometimes referred to as a keratoacanthoma-like lesion.
• A wart-like growth that may itch or feel tender.

In mucosal sites—mouth, throat, cervix—symptoms depend on location:

• Oral lesions: white or red patches, non-healing ulcers, pain when swallowing, or loose teeth.
• Oropharyngeal SCC: persistent sore throat, ear pain on one side, hoarseness, or a lump in the neck.
• Cervical SCC: abnormal vaginal bleeding, pelvic pain, or pain during intercourse.

Early SCC often grows slowly over months to years. Advanced disease presents with deeper invasion, marked ulceration, possible foul-smelling discharge, and enlarged lymph nodes. Metastatic spread can cause systemic symptoms—weight loss, fatigue, or pain in distant sites if bone or lung metastases occur.

Warning signs that call for urgent evaluation include rapid lesion growth, bleeding, non-healing ulcer, or new neurological symptoms (e.g., facial numbness if near the ear). Even minor changes in a pre-existing spot warrant medical attention. Remember, not every skin bump is cancerous, but early detection makes all the difference.

Diagnosis and Medical Evaluation

Diagnosing squamous cell carcinoma typically follows a stepwise approach:

• Clinical exam: A dermatologist or ENT specialist inspects the suspicious area, noting size, shape, color, and border irregularities.
• Dermatoscopy: Handheld magnification with polarized light helps differentiate SCC from benign lesions like seborrheic keratosis.
• Biopsy: The gold standard—punch, shave or excisional biopsy provides tissue for histopathology. Subtype, differentiation grade, and depth of invasion are assessed.
• Imaging: Ultrasound of regional lymph nodes, CT or MRI for larger tumors, and PET-CT if metastasis is suspected.
• Laboratory tests: While no specific blood test confirms cutaneous SCC, general labs (CBC, liver and renal panels) inform overall health, especially prior to surgery.

Differential diagnoses include basal cell carcinoma, keratoacanthoma, actinic keratosis (a precancerous lesion), and melanoma. For mucosal SCC, additional evaluations endoscopy, laryngoscopy or pelvic exam are often required.

Once pathology confirms SCC, staging follows TNM criteria: tumor (T) size and depth, node (N) involvement, and distant metastasis (M). Patients may go on to lymph node biopsy (sentinel node evaluation) or further imaging to complete staging before planning treatment.

Which Doctor Should You See for Squamous Cell Carcinoma?

Wondering which doctor to see for a suspicious skin lesion? A dermatologist is usually your first stop—they’re experts at diagnosing and treating skin cancers. If you notice unusual changes in the mouth, throat or cervix, you might consult an ENT specialist, oral surgeon, or gynecologist. For internal SCC of the lung or esophagus, a pulmonologist or gastroenterologist, respectively, will guide evaluation and management.

In primary care settings, family physicians often perform initial exams and refer you on. Telemedicine can help with early guidance: you can upload photos of a lesion, ask follow-up questions about biopsy results, or get a second opinion on treatment options. But remember, virtual visits complement—instead of replace—the need for in-person biopsies or urgent interventions. If a lesion bleeds heavily, is very painful, or you have rapidly swelling lymph nodes, head straight to urgent or emergency care.

Treatment Options and Management

Treatment for squamous cell carcinoma depends on stage, location and patient factors:

• Excisional surgery: Standard for most cutaneous SCC—removal with adequate margins. Mohs micrographic surgery offers highest cure rates, preserving healthy tissue in cosmetically sensitive areas.
• Radiation therapy: Used when surgery isn’t feasible (e.g., elderly patients) or as adjuvant therapy for high-risk features like perineural invasion.
• Topical treatments: 5-fluorouracil or imiquimod creams for superficial SCC in situ (Bowen’s disease).
• Photodynamic therapy: Light-activated drugs target superficial tumors but less effective on invasive SCC.
• Systemic therapy: For advanced or metastatic SCC, checkpoint inhibitors (e.g., cemiplimab, pembrolizumab) harness the immune system. EGFR inhibitors and chemotherapy play roles in select cases.
• Rehabilitation: Physical therapy, occupational therapy, and wound care optimize recovery, especially after extensive surgery or radiation.

Each option has potential side effects—scarring, pigmentation changes, mucositis or systemic toxicities—so treatment plans are tailored. Active surveillance follows therapy to catch recurrences early.

Prognosis and Possible Complications

The prognosis for cutaneous squamous cell carcinoma is generally favorable, with 5-year cure rates exceeding 90% for localized disease. Factors that worsen prognosis include tumor diameter >2 cm, depth >4 mm, perineural invasion, and immunosuppression. Mucosal or visceral SCCs carry a higher risk of recurrence and lower overall survival in advanced stages.

• Local recurrence: Risk is highest within first 2 years after treatment—regular follow-up is key.
• Lymph node metastasis: Occurs in up to 5% of cutaneous SCC; early detection via sentinel node biopsy improves outcomes.
• Distant metastasis: Rare (<2%) in skin SCC but more common in mucosal forms, affecting lungs, liver or bone.
• Complications of therapy: Chronic wounds after surgery, radiation-induced fibrosis, or immune-related adverse events with checkpoint inhibitors (colitis, hepatitis, thyroiditis).

Regular skin checks, imaging for high-risk patients, and prompt work-up of new symptoms help catch complications early and improve long-term outcomes.

Prevention and Risk Reduction

Though not all SCCs are preventable, many steps can lower your risk or catch lesions in early stages:

• Sun protection: Broad-spectrum SPF 30+, protective clothing, wide-brim hats, and shade-seeking, especially between 10 AM and 4 PM.
• Avoid tanning beds: UV from tanning booths increases SCC risk by up to 75% in young users.
• Regular skin exams: Self-exams monthly to spot new or changing lesions, with annual dermatologist visits more often if high-risk.
• Manage chronic wounds: Keep burns, ulcers, or scars under medical supervision; biopsy any non-healing area after 3 months.
• HPV vaccination: Prevents high-risk strains linked to mucosal SCC in the oropharynx and cervix.
• Tobacco and alcohol moderation: Reduces risk of head and neck SCC, with synergistic benefit when both are avoided.
• Occupational safety: Use protective gear and follow regulations when handling arsenic or industrial chemicals.

Screening guidelines vary by region, but people with previous skin cancers, immunosuppression or genetic syndromes may need more frequent evaluations. Early detection remains your best defense.

Myths and Realities

Myth 1: “Only fair-skinned people get squamous cell carcinoma.” Reality: While fair skin is a major risk factor, SCC can occur in any skin type, especially on mucous membranes or chronic scars.

Myth 2: “SCC never metastasizes.” Reality: Though less likely than some cancers, SCC can spread to lymph nodes or distant organs—early treatment matters.

Myth 3: “A small bump can’t be cancer.” Reality: Even tiny lesions under 1 cm may harbor invasive SCC. Size isn’t the sole indicator of risk.

Myth 4: “You only need sunscreen on sunny days.” Reality: UV rays penetrate clouds and windows; daily protection is key.

Myth 5: “All growths on your skin are harmless.” Reality: Many benign lesions mimic SCC. Never self-diagnose; get an expert’s view.

By sorting fact from fiction, you can adopt effective habits—sun safety, prompt check-ups—and avoid unnecessary fear from misleading claims.

Conclusion

Squamous cell carcinoma is a common but potentially serious cancer arising from squamous epithelial cells in the skin and mucous membranes. While most cases are treatable with high cure rates when caught early, advanced or inadequately treated disease carries risk of invasion and metastasis. Understanding risk factors like UV exposure, HPV infection, immunosuppression and recognizing suspicious lesions empowers timely evaluation. Professional diagnosis via biopsy and staging guides evidence-based therapies ranging from Mohs surgery to immunotherapy. Ultimately, regular skin exams, sun protection, HPV vaccination and healthy lifestyle choices are practical ways to reduce your risk. If you notice any new or changing lesion, consult a qualified healthcare provider promptly. Early action is the best defense against progression, offering peace of mind and better outcomes.

Frequently Asked Questions (FAQ)

Q1: What are early signs of squamous cell carcinoma?
A: Early signs include scaly red patches, non-healing ulcers, or raised bumps with central depression, often on sun-exposed skin.

Q2: Can squamous cell carcinoma appear inside the mouth?
A: Yes, mucosal SCC can develop on the lips, tongue, and floor of the mouth, showing as white or red patches or persistent ulcers.

Q3: How is squamous cell carcinoma diagnosed?
A: Diagnosis relies on clinical exam, dermatoscopy, and a biopsy to examine cells under a microscope and determine invasiveness.

Q4: Is squamous cell carcinoma hereditary?
A: Most SCCs aren’t directly inherited, though genetic conditions like xeroderma pigmentosum increase susceptibility.

Q5: What treatments are available?
A: Options include surgical excision, Mohs micrographic surgery, radiation, topical agents, photodynamic therapy, and systemic immunotherapy.

Q6: How quickly does untreated SCC grow?
A: Growth rate varies; some lesions evolve slowly over years, while high-risk types can invade deeper tissues in months.

Q7: Can SCC spread to lymph nodes?
A: Yes, especially tumors >2 cm, deeply invasive or with perineural invasion; sentinel node biopsy may be recommended.

Q8: How often should I get skin checks?
A: High-risk individuals may need exams every 3–6 months; others should see a dermatologist at least annually.

Q9: Does sunscreen prevent SCC?
A: Broad-spectrum sunscreen (SPF 30+) significantly reduces UV-induced DNA damage, lowering SCC risk.

Q10: Are tanning beds safe?
A: No—tanning devices emit UV radiation that increases SCC risk by up to 75% in young users.

Q11: When is emergency care needed?
A: Seek urgent care if a lesion bleeds heavily, shows rapid growth, causes severe pain, or you develop high fevers.

Q12: Can telemedicine help diagnose SCC?
A: Telemedicine allows photo-based triage and follow-up discussions, but biopsies require in-person visits.

Q13: What lifestyle changes reduce SCC risk?
A: Sun avoidance, protective clothing, quitting smoking, limiting alcohol, and wound care lower your risk.

Q14: What is the survival rate?
A: Localized cutaneous SCC has a >90% 5-year survival, decreasing with lymph node or distant spread.

Q15: Should I get HPV vaccine?
A: Yes—vaccination protects against high-risk HPV strains linked to mucosal SCC in the cervix and oropharynx.